1. Home
  2. SKLZ vs LUNG Comparison

SKLZ vs LUNG Comparison

Compare SKLZ & LUNG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Skillz Inc.

SKLZ

Skillz Inc.

HOLD

Current Price

$4.72

Market Cap

78.0M

Sector

Technology

ML Signal

HOLD

Logo Pulmonx Corporation

LUNG

Pulmonx Corporation

HOLD

Current Price

$2.22

Market Cap

63.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SKLZ
LUNG
Founded
2012
1995
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Industrial Specialties
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
78.0M
63.6M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
SKLZ
LUNG
Price
$4.72
$2.22
Analyst Decision
Buy
Buy
Analyst Count
1
7
Target Price
$14.00
$6.81
AVG Volume (30 Days)
64.5K
986.2K
Earning Date
11-06-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$92,256,000.00
$91,664,000.00
Revenue This Year
$13.33
$9.21
Revenue Next Year
$12.68
$5.03
P/E Ratio
N/A
N/A
Revenue Growth
N/A
15.59
52 Week Low
$3.54
$1.31
52 Week High
$9.11
$9.37

Technical Indicators

Market Signals
Indicator
SKLZ
LUNG
Relative Strength Index (RSI) 29.06 52.16
Support Level $5.01 $2.16
Resistance Level $5.98 $2.65
Average True Range (ATR) 0.25 0.19
MACD -0.04 -0.03
Stochastic Oscillator 3.01 36.43

Price Performance

Historical Comparison
SKLZ
LUNG

About SKLZ Skillz Inc.

Skillz Inc is a two-sided mobile gaming platform that connects developers with competitive players. The company's reportable business segments are: the Skillz segment and the Aarki segment. Skillz segment's highlights include Monetize Through Competitions, Player Matching, Cross-Platform Support, Comprehensive Analytics, and Focus on Game Development. Aarki is an artificial intelligence company that delivers advertising solutions. Some of the games available on its platform are Dominoes Gold, Blackout Bingo, 21 Blitz, and Solitaire Cube among others. The majority of its revenue is generated from the Skillz segment. Geographically, the company derives its key revenue from the United States and the rest from Israel, China, Malta, and other countries.

About LUNG Pulmonx Corporation

Pulmonx Corp is a commercial-stage medical technology company. It provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). The company's solutions are comprised of the Zephyr Endobronchial Valve, the Chartis Pulmonary Assessment System and the StratX Lung Analysis Platform. It generates revenue through the sale of products to distributors and hospitals in the United States which a key revenue generating market, Europe, Middle-East and Africa, Asia Pacific and other regions.

Share on Social Networks: